Lead discovery using molecular docking.

[1]  I D Kuntz,et al.  Predicting the structure of protein complexes: a step in the right direction. , 1996, Chemistry & biology.

[2]  S A Benner,et al.  Protein Structure Prediction , 1996, Science.

[3]  G. Rishton Reactive compounds and in vitro false positives in HTS , 1997 .

[4]  I. Kuntz,et al.  Molecular docking to ensembles of protein structures. , 1997, Journal of molecular biology.

[5]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[6]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[7]  P. Focia,et al.  Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi. , 2000, Chemistry & biology.

[8]  L. Kuhn,et al.  Virtual screening with solvation and ligand-induced complementarity , 2000 .

[9]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[10]  C. Bayly,et al.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method , 2000, J. Comput. Chem..

[11]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[12]  Araz Jakalian,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .

[13]  J S Mason,et al.  Library design and virtual screening using multiple 4-point pharmacophore fingerprints. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[14]  M. Hatada,et al.  Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Shakhnovich,et al.  Analysis of knowledge‐based protein‐ligand potentials using a self‐consistent method , 2008, Protein science : a publication of the Protein Society.

[16]  I D Kuntz,et al.  Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore. , 2000, Journal of molecular graphics & modelling.

[17]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[18]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[19]  Martin Stahl,et al.  Modifications of the scoring function in FlexX for virtual screening applications , 2000 .

[20]  G. Klebe,et al.  Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.

[21]  Robert Bywater,et al.  Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..

[22]  J A McCammon,et al.  Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.

[23]  I. Enyedy,et al.  Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. , 2001, Journal of medicinal chemistry.

[24]  Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). , 2001, Journal of medicinal chemistry.

[25]  M. Lambert,et al.  Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)+ , 2001 .

[26]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.

[27]  A. Ortiz,et al.  Evaluation of docking functions for protein-ligand docking. , 2001, Journal of medicinal chemistry.

[28]  T. Bishop,et al.  Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. , 2001, Journal of medicinal chemistry.

[29]  Malin M. Young,et al.  Design, docking, and evaluation of multiple libraries against multiple targets , 2001, Proteins.

[30]  R D Hull,et al.  Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM. , 2001, Journal of medicinal chemistry.

[31]  F. Jørgensen,et al.  A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. , 2001, Journal of medicinal chemistry.

[32]  G Klebe,et al.  A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. , 2000, Journal of molecular biology.

[33]  D. Vanderwall,et al.  Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis. , 2001, Biochimica et biophysica acta.

[34]  D. Bashford,et al.  Solvation energy density occlusion approximation for evaluation of desolvation penalties in biomolecular interactions , 2001, Proteins.

[35]  Yuan-Ping Pang,et al.  EUDOC: a computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases , 2001, J. Comput. Chem..

[36]  Ruben Abagyan,et al.  In silico discovery of novel Retinoic Acid Receptor agonist structures , 2001, BMC Structural Biology.

[37]  Y. Pang,et al.  Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases , 2001, FEBS letters.

[38]  M. Mizutani,et al.  Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis. , 2001, Journal of medicinal chemistry.

[39]  Ray Luo,et al.  Ligand-receptor docking with the Mining Minima optimizer , 2001, J. Comput. Aided Mol. Des..

[40]  I. Enyedy,et al.  Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.

[41]  Irwin D. Kuntz,et al.  Virtual Screening of Combinatorial Libraries across a Gene Family: in Search of Inhibitors of Giardia lamblia Guanine Phosphoribosyltransferase , 2001, Antimicrobial Agents and Chemotherapy.

[42]  R. García-Domenech,et al.  General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.

[43]  Thomas Lengauer,et al.  FlexE: efficient molecular docking considering protein structure variations. , 2001, Journal of molecular biology.

[44]  Gerhard Klebe,et al.  Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II. , 2001, Angewandte Chemie.

[45]  Shingo Makino,et al.  Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique , 2001, J. Comput. Aided Mol. Des..

[46]  R Abagyan,et al.  High-throughput docking for lead generation. , 2001, Current opinion in chemical biology.

[47]  R. Stroud,et al.  Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase. , 2001, Chemistry & biology.

[48]  K. Fukasawa,et al.  Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. , 2001, Journal of medicinal chemistry.

[49]  I. Muegge Effect of ligand volume correction on PMF scoring , 2001, J. Comput. Chem..

[50]  A. Caflisch,et al.  Efficient electrostatic solvation model for protein‐fragment docking , 2001, Proteins.

[51]  Jun Xu,et al.  Drug-Like Index: A New Approach to Measure Drug-Like Compounds and Their Diversity. , 2001 .

[52]  G Klebe,et al.  Docking ligands onto binding site representations derived from proteins built by homology modelling. , 2001, Journal of molecular biology.

[53]  Roberto Olender,et al.  A Fast Algorithm for Searching for Molecules Containing a Pharmacophore in Very Large Virtual Combinatorial Libraries , 2001, J. Chem. Inf. Comput. Sci..

[54]  M Karplus,et al.  Use of MCSS to design small targeted libraries: application to picornavirus ligands. , 2001, Journal of the American Chemical Society.

[55]  Wolfgang Guba,et al.  Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.

[56]  B. Shoichet,et al.  Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.

[57]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[58]  D. Goodsell,et al.  Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.

[59]  G. Whitesides,et al.  Combinatorial computational method gives new picomolar ligands for a known enzyme , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Bohdan Waszkowycz,et al.  PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. , 2002, Journal of medicinal chemistry.

[61]  Brian K. Shoichet,et al.  Structure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase , 2002 .

[62]  B. Matthews,et al.  A model binding site for testing scoring functions in molecular docking. , 2002, Journal of molecular biology.

[63]  R. Clark,et al.  Consensus scoring for ligand/protein interactions. , 2002, Journal of molecular graphics & modelling.